+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

The kinetics of urinary excretion of galactose in patients with liver diseases and normal healthy subjects



The kinetics of urinary excretion of galactose in patients with liver diseases and normal healthy subjects



Pharmaceutical Research (New York) 12(9 SUPPL ): S103




(PDF emailed within 1 workday: $29.90)

Accession: 033856351

Download citation: RISBibTeXText


Related references

Studies on healthy subjects and patients with liver diseases following intravenous and oral galactose loading. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 73: 245-250, 1967

Urinary excretion of furosemide in healthy subjects and patients with liver cirrhosis. Pharmacologia Clinica 2(4): 221-226, 1970

Urinary excretion of 17-ketosteroids in normal subjects of different age and in patients with certain endocrine diseases. Polskie Archiwum Medycyny Wewnetrznej 38(3): 335-342, 1967

Significance of urinary excretion of 8-hydroxy-2 -deoxyguanosine in healthy subjects and liver disease patients. Hepato Gastroenterology 54(78): 1736-1740, 2007

Influence of orthobiotic serum treatment on urinary excretion of 17-ketosteroids in healthy subjects or in patients with various diseases. Arch Maragliano 7(1): 21-29, 1952

Hepatic clearances of antipyrine indocyanine green and galactose in normal subjects and in patients with chronic liver diseases. Clinical Pharmacology & Therapeutics 44(2): 217-224, 1988

Urinary Hydroxyproline Excretion In Normal Subjects And In Patients Affected With Primary Diseases Of Bone. Clinica Chimica Acta; International Journal of Clinical Chemistry 11: 35-38, 1965

Effect of anabolizing steroids on BSP excretion in healthy subjects and in patients with liver diseases in the second and third stages of childhood. La Pediatria 76(1): 113-123, 1968

Plasma and urinary excretion kinetics of oral baclofen in healthy subjects. European Journal of Clinical Pharmacology 37(2): 181-184, 1989

Metabolism of ursodeoxycholic acid in normal subjects and in patients with cholestatic liver disease Biotransformation by conjugation and urinary excretion. Hepatology 16(4 PART 2): 120A, 1992

Relations between carbohydrate loading and arteriosclerosis. III. Changes in urinary excretion of catecholamines after intravenous administration of glucose in normal subjects and patients with cardiovascular diseases. Bollettino Della Societa Italiana di Biologia Sperimentale 50(13): 941-945, 1974

The hepatic galactose elimination capacity measured after a single intravenous injection of galactose in normal adults and in patients with various liver diseases. Netherlands Journal of Medicine 16(1): 2-13, 1973

The influence of glucose on the excretion of neutral 17-ketosteroid fractions by HCL and beta-glucuronidase, and of 17-ketogenic steroids in the urine of healthy subjects and patients with liver diseases. Arztliche Wochenschrift 14: 845-855, 1959

Renal excretion of galactose and galactitol in patients with classical galactosaemia, obligate heterozygous parents and healthy subjects. Journal of Inherited Metabolic Disease 26(5): 459-479, 2003

Urinary excretion of inorganic pyrophosphate by normal subjects and patients with renal calculi in north-western India and the effect of diclofenac sodium upon urinary excretion of pyrophosphate in stone formers. Urologia Internationalis 48(4): 404-408, 1992